Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ENZN $1.44 0.2260 +18.68%
ONCY $0.62 0.0800 +14.81%
XBIT $18.55 0.8300 +4.68%
CVM $0.69 0.0300 +4.55%
DVAX $24.52 0.9450 +4.01%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CBMG $33.80 -3.4000 -9.14%
OHRP $2.36 -0.1200 -4.84%
AVEO $1.66 -0.0697 -4.03%
GTXI $1.51 -0.0600 -3.82%
BPTH $1.16 -0.0450 -3.75%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Development of New Blood Vessels Not Essential to Growth of Lymph Node Metastases

(MGH) June 25, 2015 - While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed.
read press release 



New Radiotherapy Technique Could Target Prostate Cancer While Reducing Side-Effects

(ICR [UK]) June 25, 2015 - A new technique for targeting radiotherapy at prostate cancer could improve treatment for aggressive disease that has spread into pelvic lymph nodes.
read article 



Blood, Saliva Tests May Spot Head and Neck Cancers Early

(U.S. News & World Report/HealthDay News) June 24, 2015 - Scientists report they've found DNA from head and neck cancer tumors in patients' blood and saliva samples, a development that potentially could lead to early diagnosis of these malignancies.
read article 



Post-Op Radiation Therapy for Lung Ca Boosts Patient Survival

(MedPage Today/The Gupta Guide) June 24, 2015 - Post-operative radiation therapy (PORT) is associated with improved overall survival in patients with incompletely resected stage II or III non-small cell lung cancer (NSCLC,) a review of a large population-based cohort from the National Cancer Data Base indicated.
read article (free registration required) 



Merrimack Gets Priority Review for Pancreatic Cancer Drug

(NASDAQ/Dow Jones Business News) June 25, 2015 - Merrimack Pharmaceuticals Inc. said Thursday that its new drug application for a pancreatic cancer drug with Baxalta Inc., a subsidiary of Baxter International Inc., was put on priority review, sending shares up 5.9% premarket.
read article 



A Blood Test for Pancreatic Cancer May Re-Stack the Odds in Patients' Favor

(Los Angeles Times/Science Now) June 24, 2015 - Researchers at MD Anderson Cancer Center in Houston have identified a large and readily detectable molecule that circulates in the blood and has detected, with perfect accuracy and no false positives, the presence of pancreatic cancer in a small group of subjects.
read article (free registration required) 



Blood Test Might Detect Deadly Pancreatic Cancer in Early Stages

(NBC News) June 24, 2015 - With just a drop of blood doctors may one day be able to detect pancreatic cancer in its early stages, before it has become deadly, a new study suggests.
read article 



U.S. FDA Grants Priority Review for MM-398 New Drug Application

(Benzinga) June 25, 2015 - PDUFA date set for October 24, 2015; Merrimack seeking U.S. marketing approval of MM-398 for the treatment of patients with metastatic pancreatic cancer who have been previously treated with gemcitabine-based therapy; European Medicines Agency accepts Baxalta's Marketing Authorization Application for review.
read article 



AbbVie Hepatitis C Cocktail Succeeds In Late-Stage Study

(Reuters) June 24, 2015 - AbbVie Inc said on Wednesday that its hepatitis C cocktail Viekira Pak was effective whether or not it was used in combination with the compound ribavirin against the most common form of the disease, according to data from a late-stage study.
read article 



Google Reveals Health-Tracking Wristband

(Bloomberg) June 23, 2015 - Google Inc.’s life sciences group has created a health-tracking wristband that could be used in clinical trials and drug tests, giving researchers or physicians minute-by-minute data on how patients are faring.
read article 



Most Uses Of Medical Marijuana Wouldn't Pass FDA Review, Study Finds

(Los Angeles Times/Science Now) June 23, 2015 - If medical marijuana were a regular drug, it would need the blessing of the Food and Drug Administration before it could be prescribed to patients. And in most cases, those patients would be out of luck.
read article (free registration required) 



Google Genomics Adds Broad Institute's DNA Analysis Toolkit

(Reuters) June 24, 2015 - Google Genomics, the cloud-based computing business that is racing to increase its share of online DNA analytics, on Wednesday began offering a cloud service version of the popular DNA analysis software from the Broad Institute, a biomedical research organization.
read article 



Conquer Cancer Foundation Honors Six Community Oncology Practices with Clinical Trials Participation Awards

(Conquer Cancer Foundation) June 23, 2015 - The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) honored six oncology practices from throughout the United States with 2015 Clinical Trials Participation Awards (CTPA) at the ASCO Annual Meeting in Chicago.
read press release 



ESMO President 2018-2019 Announced

(Bionity.com) June 24, 2015 - The European Society for Medical Oncology (ESMO) announced that the President for the 2018-2019 period will be Josep Tabernero, Head of the Medical Oncology Department at the Vall d'Hebron University Hospital, and Director of the Vall d'Hebron Institute of Oncology (VHIO) in Barcelona, Spain.
read article 



Melanoma Research Alliance Announces More Than $13 million in New Grants for Melanoma Research

(MRA) June 23, 2015 – The Melanoma Research Alliance (MRA), the largest private funder of melanoma research, today announced grant awards of more than $13 million to conduct cutting-edge melanoma research.
read press release 



ASCO Encourages the Advancement of 21st Century Cures Legislation

(ASCO in Action) June 23, 2015 - ASCO sent a letter to U.S. House of Representatives Speaker John Boehner [R-OH] and Minority Leader Nancy Pelosi [D-CA] encouraging the advancement of H.R. 6, the 21st Century Cures Act.
read article 



Michigan Trials Take Cancer Fight To Cellular Level

(The Detroit News) June 23, 2015 - The first clinical trials in President Barack Obama's national Precision Medicine Initiative — launched in January to dramatically speed up the search for cures that attack cancer at the cellular level — will be underway at several Michigan hospitals starting in July.
read article 



Alabama Company Wins Grant To Develop Test To Measure Success Of Cancer Treatment

(The Birmingham News) June 24, 2015 - The National Institutes of Health awarded a two-year, $750,000 grant to Birmingham-based Blondin Bioscience to develop a blood test to determine whether prostate cancer treatments are working.
read article 



SPECTAlung Open to Patient Entry

(EORTC) June 22, 2015 - The first patients with thoracic malignancies are now entering SPECTAlung (EORTC trial 1335).
read article 



biOasis To File Ind For Her2+ Brain Cancer Treatment In 2016

(BioTuesdays) June 23, 2015 - biOasis hopes to file an Investigational New Drug application with the FDA next year to begin human testing of its Transcend platform against HER2 positive brain tumors, which result from HER2+ breast cancer metastasizing to the brain.
read article 



Guardant Health Partners With National Cancer Institute On First Ever Prospective Study To Implement cfDNA Genomic Profiling For Non-Small Cell Lung Cancer

(WSET-TV/ABC, Ch. 13 [Lynchburg, VA]) June 24, 2015 - Guardant Health®, the market leader in liquid biopsies, today announced that it has partnered with the National Cancer Institute (NCI)-funded SWOG on a study to use cell-free DNA testing to identify mechanisms of resistance and future treatment options in non-small cell lung cancer (NSCLC), one of the most pervasive forms of the disease.
read article 



Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A

(Bloomberg) June 23, 2015 - Amid a frenzy of biotechnology acquisitions, a clutch of companies working on a revolutionary cancer treatment have yet to be snatched up. That may be only a matter of time.
read article 



Agios Announces First Patient Dosed with AG-881 in Phase 1 Study in Patients with Advanced Solid Tumors with an IDH Mutation

(TheStreet) June 24, 2015 - Third IDH mutant inhibitor to enter clinical trials; brain penetration and pan-IDHM inhibition broaden development options for IDH mutant-positive cancers, including gliomas; second phase 1 study in hematologic malignancies on track to begin dosing in coming weeks.
read article 



Tokai Pharmaceuticals Announces Initiation of Phase 3 ARMOR3-SV Trial of Galeterone in AR-V7 Positive Metastatic Castration-Resistant Prostate Cancer

(MarketWatch) June 24, 2015 - ARMOR3-SV represents the first precision medicine-based pivotal clinical trial in prostate cancer; topline data expected by the end of 2016; AR-V7 clinical trial assay components finalized.
read article 



Local Patients’ Help Re-Define Low-Grade Brain Tumor Diagnosis

(Henry Ford Health System) June 24, 2015 - Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified – and ultimately treated.
read press release